Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
US6713053B1 · kind B1 · utility
10Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 1998 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Aug 18, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition for treating an auto-immune disease, particularly an auto-immune disease induced by a defect in CD4+ T cell immunoregulation, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.